MDDRX | VIVIX | MDDRX / VIVIX | |
Total Expense Ratio | 1.09 | 0.04 | 2,725% |
Annual Report Gross Expense Ratio | 1.09 | 0.04 | 2,725% |
Fund Existence | 11 years | 27 years | - |
Gain YTD | 12.508 | 7.866 | 159% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 320M | 203B | 0% |
Annual Yield % from dividends | 1.26 | 2.11 | 60% |
Returns for 1 year | -17.69 | 7.74 | -229% |
Returns for 3 years | -5.68 | 36.61 | -16% |
Returns for 5 years | 13.42 | 70.16 | 19% |
Returns for 10 years | -11.24 | 131.61 | -9% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WELNX | 10.71 | 0.15 | +1.42% |
William Blair Emerging Mkts Ldrs N | |||
RLAIX | 21.30 | 0.19 | +0.90% |
T. Rowe Price Latin America I | |||
RNWBX | 86.97 | 0.63 | +0.73% |
American Funds New World R2 | |||
GCMCX | 30.23 | 0.03 | +0.10% |
Goldman Sachs Mid Cap Value C | |||
GVIRX | 18.24 | -0.04 | -0.22% |
Goldman Sachs US Eq Div and Premium Inv |